NeueHealth, Inc.
NEUE · NYSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | -0.02 | 0.07 | 0.12 |
| FCF Yield | -7.38% | -38.10% | -41.26% | -51.67% |
| EV / EBITDA | -4.07 | 14.46 | -5.48 | -3.75 |
| Quality | ||||
| ROIC | -8.73% | -1.72% | 17.67% | 11.06% |
| Gross Margin | 29.97% | 25.44% | 20.52% | 21.57% |
| Cash Conversion Ratio | 1.83 | 9.04 | 0.51 | 0.39 |
| Growth | ||||
| Revenue 3-Year CAGR | -34.97% | -41.43% | -44.89% | -45.05% |
| Free Cash Flow Growth | 79.83% | 12.35% | -12.74% | 23.61% |
| Safety | ||||
| Net Debt / EBITDA | -7.57 | 7.93 | -3.64 | -0.73 |
| Interest Coverage | 2.07 | 0.40 | -4.71 | -3.20 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 97.87 | 146.00 | -49.44 | 13.74 |